| Identification | Back Directory | [Name]
Lanosta-7,9(11),24-trien-21-oic acid, 23-hydroxy-3-oxo-, γ-lactone, (13α,14β,17α,20S,23R)- | [CAS]
106533-51-1 | [Synonyms]
Nimolinone
11-Nimolinone
D9,11-Nimolinone
Lanosta-7,9(11),24-trien-21-oic acid, 23-hydroxy-3-oxo-, γ-lactone, (13α,14β,17α,20S,23R)- | [Molecular Formula]
C30H42O3 | [MOL File]
106533-51-1.mol | [Molecular Weight]
450.66 |
| Hazard Information | Back Directory | [Description]
Nimolinone is presented in EENL. Analysis of the compounds in the EENL by mass spectrometry suggests the presence of nimbolide, 2',3'-dehydrosalannol, 6-desacetyl nimbinene, and nimolinone. Antiproliferative activity of nimbolide and 2',3'-dehydrosalannol in HUVECs. EENL by regulating the genes involved in cellular development and cell death functions could control cell proliferation, attenuate the stimulatory effects of VEGF, and exert antiangiogenic effects. EENL treatment could have a potential therapeutic role during cancer progression. |
|
|